Prolight Diagnostics

Prolight Diagnostics is a company focused on developing innovative Point-of-Care (POC) systems. These systems are designed to be small, portable instruments along with disposable cartridges for in-vitro diagnostic (IVD) tests using only a drop of blood. Their primary goal is to provide top-notch POC systems in the market that enable quick and reliable diagnosis of acute events. The company's initial product launch will focus on the measurement of troponin to assist in ruling in and ruling out myocardial infarction, addressing a critical need in healthcare. Prolight Diagnostics is listed on the NGM Nordic SME marketplace under the ticker PRLD. With the potential to revolutionize point-of-care diagnostics, Prolight Diagnostics presents a promising investment opportunity for venture capitalists seeking innovation in the healthcare industry.